Kala Pharmaceuticals Inc. buy me8
Start price
28.12.22
/
0%
€32.60
Target price
28.12.23
€40.00
Performance (%)
50.15%
End price
02.01.23
€48.95
Summary
This prediction ended on 02.01.23 with a price of €48.95. With a performance of 50.15% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -28.638% | -28.638% | -96.461% | -98.780% |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % | 50,82 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % | 90,84 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % | 51,21 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % | 62,94 % |
Comments by me8 for this prediction
In the thread Kala Pharmaceuticals Inc. diskutieren
Buy Kala Pharmaceuticals Inc.
Kursziel gesetzt auf 40,0